# The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry

> **NCT00402207** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 33 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** extrafine HFA-beclomethasone
- **DRUG:** HFA-fluticasone

## Key facts

- **NCT ID:** NCT00402207
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 33 (—)
- **Last updated:** 2006-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402207, "The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00402207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*